They appear to be hitting some milestones. The Sydney plant has TGA approval, a deal has been done with the QLD Gov for a new 1m Ltr facility and their Covid Hyperimmune is nearing completion of final trials (for the technically minded there is a report coauthored with Kirby Institute explaining impressive outcomes). If their (Aegros) latest YouTube video is taken at face value, Macquarie are casting around for a cornerstone investor at a $1b valuation.
if things are as good as they look it makes me wonder why CSL haven’t bought them out? Why allow a competitor with superior technology (in theory) to get established?
Is Aegros a genuine Threat to CSL?, page-10
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$286.95 |
Change
3.900(1.38%) |
Mkt cap ! $138.6B | |||
| Open | High | Low | Value | Volume |
| $286.49 | $287.25 | $284.10 | $277.6M | 968.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 204 | $286.95 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $287.00 | 839 | 4 |
View Market Depth
| Last trade - 16.10pm 16/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$286.46 |
Change
3.900 ( 0.87 %) |
||||
| Open | High | Low | Volume | ||
| $286.01 | $287.24 | $284.18 | 175932 | ||
| Last updated 15.59pm 16/05/2024 ? | |||||
| CSL (ASX) Chart |